← Leaderboards
Rizwan Hamid
Vanderbilt University
$10,654,735
Attributed
$20,557,689
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,557,689 · 6
By mechanism
U01$13,923,998 · 2
R01$4,820,970 · 2
P01$1,372,147 · 1
K08$440,574 · 1
Top collaborators
- John Atlas Phillips Iii18 shared
- Joy D Cogan14 shared
- John Hughes Newman11 shared
- Lisa Bastarache2 shared
- Thomas Anthony Cassini2 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- John Atlas Phillips III$14,651,319
- John Hughes Newman$11,268,781
- Digna R Velez Edwards$11,329,288
- Kelly A Birdwell$3,186,569
- Joshua C. Denny$39,465,922
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeResourcesDiagnosisDatabasesBioinformaticsPhysiciansCohortGenesEnsureScientistStructureCollaborationsResearch PersonnelDiagnosticVariantGenotypeDiagnostic ProcedureFundingLeadDiagnostic TestsCaringExhaustDna DatabasesPersons
Grant awards (37)
Vanderbilt Center of Excellence for Undiagnosed Disease (VCEUD)$852,879
U01 · FY2025 · NS · contact PI
Vanderbilt Center of Excellence for Undiagnosed Disease (VCEUD)$880,822
U01 · FY2024 · NS · contact PI
Vanderbilt Center for Undiagnosed Diseases (VCUD)$681,250
U01 · FY2023 · NS · contact PI
Vanderbilt Center for Undiagnosed Diseases (VCUD)$331,850
U01 · FY2023 · NS · contact PI
Vanderbilt Center for Undiagnosed Diseases (VCUD)$750,335
U01 · FY2022 · HG · contact PI
Vanderbilt Center for Undiagnosed Diseases (VCUD)$302,000
U01 · FY2022 · HG · contact PI
Vanderbilt Center for Undiagnosed Diseases (VCUD) - Biorepository$60,000
U01 · FY2022 · HG · contact PI
Vanderbilt Center for Undiagnosed Diseases (VCUD)$1,100,000
U01 · FY2021 · HG · contact PI
Genomic Analysis and Statistical Core$274,430
P01 · FY2021 · HL · contact PI
Vanderbilt Center for Undiagnosed Diseases (VCUD)$104,463
U01 · FY2021 · HG · contact PI
Vanderbilt Center for Undiagnosed Diseases (VCUD)$1,100,000
U01 · FY2020 · HG · contact PI
Role of bone marrow cells in pathogenesis and therapy of heritable pulmonary arterial hypertension$634,580
R01 · FY2020 · HL · contact PI
Genomic Analysis and Statistical Core$274,429
P01 · FY2020 · HL · contact PI
Vanderbilt Center for Undiagnosed Diseases (VCUD)$100,699
U01 · FY2020 · HG · contact PI
Vanderbilt Center for Undiagnosed Diseases (VCUD)$1,500,000
U01 · FY2019 · HG · contact PI
Role of bone marrow cells in pathogenesis and therapy of heritable pulmonary arterial hypertension$634,580
R01 · FY2019 · HL · contact PI
Genomic Analysis and Statistical Core$274,429
P01 · FY2019 · HL · contact PI
Vanderbilt Center for Undiagnosed Diseases (VCUD)$142,377
U01 · FY2019 · HG
Vanderbilt Center for Undiagnosed Diseases (VCUD)$1,420,000
U01 · FY2018 · HG
Role of bone marrow cells in pathogenesis and therapy of heritable pulmonary arterial hypertension$617,311
R01 · FY2018 · HL · contact PI
Genomic Analysis and Statistical Core$274,429
P01 · FY2018 · HL · contact PI
Vanderbilt Center for Undiagnosed Diseases (VCUD)$200,791
U01 · FY2018 · HG
Vanderbilt Center for Undiagnosed Diseases (VCUD)$2,093,452
U01 · FY2017 · HG
Role of bone marrow cells in pathogenesis and therapy of heritable pulmonary arterial hypertension$617,311
R01 · FY2017 · HL · contact PI
Genomic Analysis and Statistical Core$274,430
P01 · FY2017 · HL · contact PI
Vanderbilt Center for Undiagnosed Diseases (VCUD)$2,094,080
U01 · FY2016 · HG
Vanderbilt Center for Undiagnosed Diseases (VCUD)$209,000
U01 · FY2016 · HG
Role of BMPR2 expression in HPAH; implications for novel therapeutic approaches$271,477
R01 · FY2015 · HL · contact PI
Role of BMPR2 expression in HPAH; implications for novel therapeutic approaches$180,943
R01 · FY2015 · HL · contact PI
Role of BMPR2 expression in HPAH; implications for novel therapeutic approaches$467,178
R01 · FY2014 · HL · contact PI
Role of BMPR2 expression in HPAH; implications for novel therapeutic approaches$460,160
R01 · FY2013 · HL · contact PI
Role of BMPR2 expression in HPAH; implications for novel therapeutic approaches$483,287
R01 · FY2012 · HL · contact PI
Functions of the TG-Interacting Transcription Factor (TGIF) in Hematopoiesis$96,897
K08 · FY2012 · HL · contact PI
Role of BMPR2 expression in HPAH; implications for novel therapeutic approaches$454,143
R01 · FY2011 · HL · contact PI
Functions of the TG-Interacting Transcription Factor (TGIF) in Hematopoiesis$94,861
K08 · FY2011 · HL · contact PI
Functions of the TG-Interacting Transcription Factor (TGIF) in Hematopoiesis$124,408
K08 · FY2010 · HL · contact PI
Functions of the TG-Interacting Transcription Factor (TGIF) in Hematopoiesis$124,408
K08 · FY2009 · HL · contact PI